🇺🇸 FDA
Patent

US 7301024

Crystalline forms of gatifloxacin and processes for preparation

granted A61PA61P31/00A61P31/04

Quick answer

US patent 7301024 (Crystalline forms of gatifloxacin and processes for preparation) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Nov 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P31/00, A61P31/04